The Board of Affluent Partners Holdings Limited announced that, with effect on 26 March 2024, Dr. Su Yaoyao has been appointed as an executive Director of the Company, one of the Authorised Representatives and Process Agent. Dr. Su, aged 41, has been the general manager of Beijing Baijing Biotechnology Company Limited since March 2022 and was the general manager of Hangzhou Qingda Kerui Biological Technology Co. Ltd. from September 2018 to March 2022.

Dr. Su graduated from Southeast University with a bachelor's degree in public health and PhD degree in public health in 2006 and 2012 respectively. The Board further announced that Mr. Cheng Chi Kin ("Mr. Cheng''), the Chairman of the Board and an executive Director, has resigned from his role as Chairman and re-designated as a non-executive Director with effect from 26 March 2024, due to his other business commitments. Mr. Cheng has also resigned as a member of the Remuneration Committee and Nomination Committee of the Board, and will cease to act as one of the Authorised Representatives and the Process Agent on the same date.

Mr. Cheng Chi Kin, aged 55, was appointed as an executive director and the Chairman of the Board of the Company on 27 September 2019 and 18 October 2019 respectively. He obtained a Degree in Business Studies from University of Glamorgan in 1992 and a Master Degree in Business Administration from Cardiff Business School in 1993. He is a fellow member of Hong Kong Institute of Certified Public Accountants and a fellow member of the Association of International Accountants.

He is also a Chartered Marketer of The Chartered Institute of Marketing and a member of Institute of Management Accountants. He has over 28 years of working experience in merger and acquisition, finance and accounting, banking, asset management and funds operations in various industries including real estate developments, infrastructure developments, real estate investment trusts (REITS), securities investments and natural resources industries. Mr. Cheng was an executive director and the chief executive officer of China Uptown Group Company Limited from June 2022 to March 2024, an executive director of DeTai New Energy Group Limited from August 2021 to March 2024 and the chairman of the board of the same company from November 2021 to March 2024, and the shares of both companies are listed on the Main Board of the Stock Exchange.

The Board further announced that following the appointment of Dr. Su and re-designation of Mr. Cheng, both Mr. Cheung Sze Ming, an executive Director, and Dr. Su will be appointed as members of the Remuneration Committee and Nomination Committee of the Board on 26 March 2024.